|
| Press Releases |
|
 |
|
| Monday, November 17, 2025 |
|
|
JBM Healthcare Announces FY2026 Interim Results |
| JBM (Healthcare) Limited ('JBM Healthcare' or the 'Company', Stock Code: 2161, together with its subsidiaries, the 'Group'), a leading branded healthcare products marketer and distributor in Hong Kong, today announced its interim results for the six months ended 30 September 2025 ('FY2026 Interim' or the 'Reporting Period'). more info >> |
|
| Thursday, June 12, 2025 |
|
|
JBM Healthcare Delivers Strong FY2025 Annual Results, Net Profit Surged 51.2% to HK$197.3 Million |
| JBM (Healthcare) Limited ('JBM Healthcare' or the 'Company'; Stock Code: 2161, together with its subsidiaries, the 'Group'), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the annual results of the Group for the year ended 31 March 2025 ('FY2025' or the 'Reporting Period'). more info >> |
|
| Thursday, April 3, 2025 |
|
|
JBM Healthcare Completes Acquisition of 90% Interest in Tin Hee Tong |
| JBM (Healthcare) Limited ("JBM Healthcare"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, announced today that it has acquired a 90% stake in Tin Hee Tong Medicine Factory, Limited ("Tin Hee Tong",), at a total consideration of HK$171.0 million. more info >> |
|
| Tuesday, November 19, 2024 |
|
|
JBM Healthcare Announces FY2025 Interim Results |
| more info >> |
|
| Monday, November 4, 2024 |
|
|
JBM Healthcare Issues Positive Profit Alert |
| JBM (Healthcare) Limited ('JBM Healthcare' or the 'Company'; Stock Code: 2161, together with its subsidiaries, the 'Group'), a leading branded healthcare products marketer and distributor in Hong Kong, has today announced a positive profit alert. Based on a preliminary review of the unaudited consolidated management accounts of the Group for the six months ended 30 September 2024 and the information currently available to the board of directors of the Company, the Group expects to record an increase in the consolidated profit attributable to shareholders for the six months ended 30 September 2024 ('Consolidated Profit') by not less than 50% as compared to that for the same period last year. more info >> |
|
| Tuesday, June 18, 2024 |
|
|
JBM Healthcare Announces FY2024 Annual Results |
| JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the annual results of the Group for the year ended 31 March 2024 ("FY2024" or the "Reporting Period"). more info >> |
|
| Sunday, May 5, 2024 |
|
|
JBM Healthcare Issues Positive Profit Alert |
| JBM (Healthcare) Limited has announced a positive profit alert. Based on a preliminary review of the unaudited consolidated management accounts of the Group for the financial year ended 31 March 2024 and the information currently available to the board of directors of the Company, the Group is expected to record an increase in the consolidated profit attributable to shareholders for the year ended 31 March 2024 ("Consolidated Profit") by not less than 120% as compared to that for the same period last year. more info >> |
|
| Wednesday, November 22, 2023 |
|
|
JBM Healthcare Announces FY2024 Interim Results |
| JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the interim results of the Group for the six months ended 30 September 2023 (the "Reporting Period"). more info >> |
|
| Thursday, June 15, 2023 |
|
|
JBM Healthcare Announces FY2023 Annual Results |
| JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the annual results of the Group for the year ended 31 March 2023 ("FY2023" or the "Reporting Period"). more info >> |
|
| Friday, November 25, 2022 |
|
|
JBM Healthcare Announces FY2023 Interim Results |
| JBM (Healthcare) Limited ("JBM Healthcare" or the "Group"; Stock Code: 2161), a leading branded healthcare products marketer and distributor in Hong Kong, has announced today the interim results of the Group for the six months ended 30 September 2022 (the "Reporting Period"). more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
OMP Positioned Highest for Both Completeness of Vision and Ability to Execute in the 2026 Gartner(R) Magic Quadrant(TM) for Supply Chain Planning Solutions: Process Industries
Mar 23, 2026 23:15 HKT/SGT
|
|
|
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Mar 23, 2026 21:05 HKT/SGT
|
|
|
Essex Bio-Technology Reports Robust Results for FY2025, Turnover Soars 8.6% to HK$1814 million, Net Profit up 3.5% to HK$ 318.1 million, Total Dividend Increases by 16.7% to HK14 Cents per Share
Mar 23, 2026 20:51 HKT/SGT
|
|
|
GMG Launches European Sales Team; G(R) Lubricant Patent Accepted for Europe
Mar 23, 2026 20:29 HKT/SGT
|
|
|
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint
Mar 23, 2026 18:59 HKT/SGT
|
|
|
From SGD to Global Spending: How Singaporeans Can Avoid FX Fees While Travelling Overseas
Mar 23, 2026 14:15 HKT/SGT
|
|
|
Fujitsu-developed traffic simulation system utilized in Maebashi City's public transportation planning
Mar 23, 2026 14:24 JST
|
|
|
Hitachi Receives the 2026 Catalyst Award, a Global Recognition for Building an Inclusive Organization
Mar 23, 2026 11:49 JST
|
|
|
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026
Mar 23, 2026 11:19 JST
|
|
|
Unitree Robotics IPO Ignites Embodied-Intelligence Rally, Shoucheng Holdings (0697.HK) Faces a Dual Catalyst of 'Investment Realisation+Platform Re-Rating'
Mar 23, 2026 08:22 HKT/SGT
|
|
|
AEM and ASE Enter Strategic Partnership to Accelerate AI and HPC Test Innovation
Mar 23, 2026 08:00 HKT/SGT
|
|
|
FILMART and EntertainmentPulse draw about 8,000 industry participants
Mar 20, 2026 20:40 HKT/SGT
|
|
|
TANAKA Announces Executive Appointments
Mar 20, 2026 20:00 HKT/SGT
|
|
|
MarketingPulse and eTailingPulse attract more than 1,700 industry professionals
Mar 20, 2026 11:42 HKT/SGT
|
|
|
Anticipation of Unitree Robotics' IPO Heats Up, Value Revaluation for Shoucheng Holdings (0697.HK) Expected
Mar 20, 2026 08:30 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
